Éric Bruckert
Impact in
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 0.02%
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 81
- Surgery 215
- Lipoproteins and Cardiovascular Health 188
- Cholesterol and Lipid Metabolism 30
- Co-authors
- Philippe Giral (65 shared papers)Thierry Poynard (8 shared papers)Vlad Ratziu (7 shared papers)Frédéric Charlotte (6 shared papers)Sylvie Dejager (12 shared papers)Gérard Turpin (39 shared papers)Bernard Hainque (13 shared papers)Claude Jardel (10 shared papers)
- Journals
- Atherosclerosis (52 papers)Journal of clinical lipidology (20 papers)European Heart Journal (15 papers)Arteriosclerosis Thrombosis and Vascular Biology (11 papers)Journal of the American College of Cardiology (9 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Éric Bruckert
412 papers receiving 33.0k citations
Éric Bruckert's Hit Papers
Peers
Comparison fields: 5 of 171
- Endocrinology, Diabetes and Metabolism 7.4k
- Surgery 16.0k
- Cancer Research 3.4k
- Cardiology and Cardiovascular Medicine 5.1k
- Epidemiology 6.0k
Countries citing papers authored by Éric Bruckert
This map shows the geographic impact of Éric Bruckert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Bruckert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Bruckert more than expected).
Fields of papers citing papers by Éric Bruckert
This network shows the impact of papers produced by Éric Bruckert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Bruckert. The network helps show where Éric Bruckert may publish in the future.
Co-authors
The 25 scholars most cited alongside Éric Bruckert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 428 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel Hit paper breakdown → | 2017 | 2815 |
| 2 | Mutations in PCSK9 cause autosomal dominant hypercholesterolemia Hit paper breakdown → | 2003 | 2442 |
| 3 | Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2005 | 1760 |
| 4 | Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel Hit paper breakdown → | 2020 | 1143 |
| 5 | Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management Hit paper breakdown → | 2015 | 1137 |
| 6 | Mild to Moderate Muscular Symptoms with High-Dosage Statin Therapy in Hyperlipidemic Patients —The PRIMO Study Hit paper breakdown → | 2005 | 1024 |
| 7 | Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss* Hit paper breakdown → | 2000 | 881 |
| 8 | Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society Hit paper breakdown → | 2014 | 843 |
| 9 | Liver fibrosis in overweight patients Hit paper breakdown → | 2000 | 834 |
| 10 | Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment Hit paper breakdown → | 2015 | 680 |
| 11 | Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine Hit paper breakdown → | 2016 | 622 |
| 12 | Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial Hit paper breakdown → | 2008 | 538 |
| 13 | Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome Hit paper breakdown → | 2019 | 497 |
| 14 | The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management Hit paper breakdown → | 2013 | 496 |
| 15 | 2002 | 486 | |
| 16 | Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance Hit paper breakdown → | 2014 | 463 |
| 17 | Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance Hit paper breakdown → | 2016 | 437 |
| 18 | Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial Hit paper breakdown → | 2015 | 408 |
| 19 | 2004 | 393 | |
| 20 | 2002 | 392 |
About Éric Bruckert
Éric Bruckert is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Cancer Research, Cardiology and Cardiovascular Medicine and Biochemistry, having authored 428 papers that have together received 34.5k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (188 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (81 papers), Cancer, Lipids, and Metabolism (40 papers), Lipid metabolism and disorders (32 papers), Cholesterol and Lipid Metabolism (30 papers), Health Systems, Economic Evaluations, Quality of Life (18 papers), Liver Disease Diagnosis and Treatment (14 papers) and Antioxidant Activity and Oxidative Stress (13 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (7.4k citations), Surgery (16.0k citations), Cancer Research (3.4k citations), Cardiology and Cardiovascular Medicine (5.1k citations) and Epidemiology (6.0k citations). Éric Bruckert has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Philippe Giral, Thierry Poynard, Vlad Ratziu, Frédéric Charlotte, Sylvie Dejager, Gérard Turpin, Bernard Hainque, Claude Jardel, André Grimaldi and M. John Chapman. Their work appears in journals such as Atherosclerosis, Journal of clinical lipidology, European Heart Journal, Arteriosclerosis Thrombosis and Vascular Biology and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.